Inventor · disambiguated record
Merav Beiman
Also filed as: BEIMAN MERAV
10 granted patents·18 pending applications·26 citations·filing 2004–2024
87Inventor score
Top patents by PatentIndex Score
28 records- 0185US8415455B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsLEVINE ZURIT·Filed 2008·Granted Apr 9, 2013·9 cites·14 claims
- 0284US9107862B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Aug 18, 2015·5 cites·9 claims
- 0381US9375466B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Jun 28, 2016·3 cites·4 claims
- 0478US8349801B2Peptide ligands for G-protein coupled receptorsCOMPUGEN LTD·Filed 2007·Granted Jan 8, 2013·2 cites·12 claims
- 0578US7678769B2Hepatocyte growth factor receptor splice variants and methods of using sameCOMPUGEN LTD·Filed 2007·Granted Mar 16, 2010·1 cites·6 claims
- 0676US2024139238A1Universal platform for car therapy targeting a novel antigenic signature of cancerGAVISH GALILEE BIO APPL LTD·Filed 2024·Application pending·0 cites
- 0774US9555087B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2014·Granted Jan 31, 2017·1 cites·27 claims
- 0874US2022380434A1Universal platform for car therapy targeting a novel antigenic signature of cancerMIGAL GALILEE RES INSTITUTE LTD·Filed 2022·Application pending·0 cites
- 0973US10098934B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Oct 16, 2018·1 cites·9 claims
- 1073US7758862B2Hepatocyte growth factor receptor splice variants and methods of using sameCOMPUGEN LTD·Filed 2006·Granted Jul 20, 2010·2 cites·16 claims
- 1173US7601692B2MCP-1 splice variants and methods of using sameCOMPUGEN LTD·Filed 2006·Granted Oct 13, 2009·2 cites·4 claims
- 1270US2021230251A1Universal platform for car therapy targeting a novel antigenic signature of cancerGAVISH GALILEE BIO APPL LTD·Filed 2021·Application pending·0 cites
- 1369US2011311450A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsLEVINE ZURIT·Filed 2009·Application pending·0 cites
- 1463US2018298109A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2018·Application pending·0 cites
- 1561US11660315B2Universal platform for preparing an inhibitory chimeric antigen receptor (iCAR)IMMPACT BIO LTD·Filed 2018·Granted May 30, 2023·0 cites·11 claims
- 1661US2019248869A1A universal platform for car therapy targeting a novel antigenic signature of cancerGAVISH GALILEE BIO APPL LTD·Filed 2017·Application pending·0 cites
- 1758US2021244759A1Universal platform for car therapy targeting a novel antigenic signature of cancerIMMPACT BIO LTD·Filed 2021·Application pending·0 cites
- 1858US2017037141A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 1956US2016068606A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2015·Application pending·0 cites
- 2055US2017107284A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 2152US2016177395A1Biomarkers for the prediction of renal injuryCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 2250US2007219125A1Novel thrombospondin-1 polynucleotides encoding variant thrombospondin-1 polypeptides and methods using sameCOJOCARU GAD S·Filed 2007·Application pending·0 cites
- 2348US2005123538A1Polynucleotides encoding novel ErbB-2 polypeptides and kits and methods using sameFiled 2004·Application pending·0 cites
- 2446US2020316120A1METHODS FOR IDENTIFYING ACTIVATING ANTIGEN RECEPTOR (aCAR)/INHIBITORY CHIMERIC ANTIGEN RECEPTOR (iCAR) PAIRS FOR USE IN CANCER THERAPIESIMMPACT BIO LTD·Filed 2019·Application pending·0 cites
- 2544US2011003708A1Biomarkers for the prediction of renal injuryCOMPUGEN LTD·Filed 2010·Application pending·0 cites
- 2641US2009035287A1Atrial natriuretic peptide (anp) splice variants and methods of using sameLEVINE ZURIT·Filed 2006·Application pending·0 cites
- 2736US2010183573A1Hepatocyte growth factor receptor splice variants and methods of using sameCOMPUGEN LTD·Filed 2010·Application pending·0 cites
- 2835US2010166733A1Mcp-1 splice variants and methods of using sameLEVIN ZURIT·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Merav Beiman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →